STOCK TITAN

USANA (USNA) director Gilbert Fuller sells 1,058 shares, now holds none

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

USANA Health Sciences director Gilbert A. Fuller sold shares in an open-market transaction. He sold 1,058 shares of common stock at a price of $17.00 per share. After this sale, the filing shows he directly owns 0 shares of USANA common stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
FULLER GILBERT A

(Last)(First)(Middle)
3838 WEST PARKWAY BLVD

(Street)
SALT LAKE CITY UTAH 84120

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
USANA HEALTH SCIENCES INC [ USNA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/20/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/20/2026S1,058D$170D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Joshua Foukas, Attorney-in-Fact03/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did USANA (USNA) director Gilbert A. Fuller report?

Director Gilbert A. Fuller reported an open-market sale of USANA common stock. He sold 1,058 shares at a price of $17.00 per share, and after this transaction, the filing shows he directly holds 0 shares of USANA common stock.

How many USANA (USNA) shares did Gilbert A. Fuller sell and at what price?

Gilbert A. Fuller sold 1,058 shares of USANA common stock in a single transaction. The reported sale price was $17.00 per share, and following this sale, his reported direct ownership position in USANA common stock was reduced to 0 shares.

Was the USANA (USNA) insider transaction an open-market sale or another type?

The transaction was an open-market sale of USANA common stock. The Form 4 classifies it under transaction code “S,” described as a sale in an open market or private transaction, with 1,058 shares sold at $17.00 per share by director Gilbert A. Fuller.

What is Gilbert A. Fuller’s USANA (USNA) share ownership after the reported sale?

After the reported open-market sale, the Form 4 shows Gilbert A. Fuller directly owns 0 shares of USANA common stock. The transaction involved selling 1,058 shares at $17.00 per share, and no remaining derivative positions are listed in the filing’s derivative summary.

Does the USANA (USNA) Form 4 show any option exercises or derivative positions for Gilbert A. Fuller?

The Form 4 lists no derivative transactions or remaining derivative positions for Gilbert A. Fuller. The filing reports only one non-derivative transaction: the open-market sale of 1,058 USANA common shares at $17.00 per share, leaving his reported direct holdings at 0 shares.
Usana Health Sciences Inc

NYSE:USNA

View USNA Stock Overview

USNA Rankings

USNA Latest News

USNA Latest SEC Filings

USNA Stock Data

312.42M
10.37M
Packaged Foods
Medicinal Chemicals & Botanical Products
Link
United States
SALT LAKE CITY